Prevalence of Gastroesophageal Reflux During Childhood and Teenage Years in France
NCT ID: NCT00681837
Last Updated: 2008-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2500 participants
OBSERVATIONAL
2008-05-31
2008-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
National Survey on GERD Patients (Adults and Children)
NCT00833573
Natural History of Gastroesophageal Reflux (GER) in Children and Adolescents
NCT00181805
National Survey on Gastroesophageal Reflux Disease (GERD) Patients
NCT00695838
Retrospective Observational Study on GERD Management in General Hospitals in Korea
NCT06974903
Functional and Molecular Characterisation of Oesophageal Distal Epithelium: Correlations With Acid and Non Acid Reflux
NCT00231881
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
children from 0 to 17 years old
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frédéric GOTTRAND
Role: STUDY_CHAIR
CHRU Lille - France
Geneviève BONNELYE
Role: PRINCIPAL_INVESTIGATOR
TNS Healthcare 92120 Montrouge - France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Hefei, Anhui, China
Research Site
Chongqing, Chongqing Municipality, China
Research Site
Fuzhou, Fujian, China
Research Site
Guangzhou, Guangdong, China
Research Site
Shenzhen, Guangdong, China
Research Site
Xiamen, Guangdong, China
Research Site
Zhongshan, Guangdong, China
Research Site
Zhengzhou, Henan, China
Research Site
Wuhan, Hubei, China
Research Site
Changsha, Hunan, China
Research Site
Nanjing, Jiangsu, China
Research Site
Suzhou, Jiangsu, China
Research Site
Wuxi, Jiangsu, China
Research Site
Nanchang, Jiangxi, China
Research Site
Jinan, Shandong, China
Research Site
Qingdao, Shandong, China
Research Site
Shanghai, Shanghai Municipality, China
Research Site
Taiyuan, Shanxi, China
Research Site
Xi’an, Shanxi, China
Research Site
Chengdu, Sichuan, China
Research Site
Kunming, Yunnan, China
Research Site
Hangzhou, Zhejiang, China
Research Site
Ningbo, Zhejiang, China
Research Site
Rui’an, Zhejiang, China
Research Site
Wenzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-GFR-DUM-2008/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.